WuXi Biologics

WuXi Biologics is thrilled to announce the successful conclusion of our participation in BMA 2025 (Mar 12-13 at Sands Expo & Convention Centre, Singapore). At Booth #46, we showcased cutting-edge technologies and solutions in biologics manufacturing, attracting numerous visitors. Our keynote speeches by Dr. Wei Guo and Dr. Hang Zhou sparked insightful discussions on industry advancements. Notably, we were honored to receive an award at the Asia Bioprocessing Excellence Awards (ABEA) 2025. This recognition motivates us to continue driving innovation and delivering superior services. We extend our gratitude to all participants, organizers, and partners who contributed to the event's success. Looking ahead, Wuxi Biologics remains dedicated to pushing boundaries in biologics manufacturing and fostering collaborative growth in the biopharmaceutical industry. #BiologicsManufacturing #BMA2025 #AsiaBioprocessingExcellence #LifeSciences #ManufacturingExcellence

If you are attending the Microbial Engineering III Conference from March 30 to April 3 in Porto, Portugal, let's connect and discuss your goals for R&D and drug manufacturing. Sam Zhang, PhD, VP, Head of Microbial and Viral Platforms at WuXi Biologics, speaks Monday, March 31 at 4:30 PM WET. His presentation features “A revitalized E. coli platform to drive the development and manufacturing of new biologic modalities." The platform is the a newly launched microbial expression system EffiX™, which supports high-yield protein and plasmid production. Contact us and we'll set up a convenient time to discuss your outsourcing and partnership needs. Request a meeting: https://lnkd.in/gvNFGynY #MicrobialEngineering #pDNA #recombinant protein #E. coli #biomanufacturing #ResearchAndDevelopment #Biotechnology

The WuXiHigh™ platform is a proprietary and revolutionary high concentration (up to 230 mg/mL) biopharmaceutical development platform, incorporating features such as novel methodology in viscosity reduction, synergistic excipient combinations, computer-assisted formulation development and high-throughput formulation screening strategies. The platform offers innovative solutions for our clients and the platform can be tailored for various biopharmaceuticals, including monoclonal antibodies (mAb), bispecific antibodies (BsAb), fusion proteins and other types of biologics. https://lnkd.in/eUQJugYB #drugproducts #drugformulation #drugproductdevelopment

Will you be attending the World Vaccines Congress (April 22-24) in Washington, DC? If so, our team will be available at booth #571 to discuss your 2025 drug development and manufacturing goals. Contact us and we’ll set up a convenient time to learn about your outsourcing or partnering needs. You may also request a meeting here: https://lnkd.in/e_iR7WV9 #WorldVaccinesCongress #Vaccines #DrugDevelopment #WashingtonDC #ClinicalTrials #Outsourcing #Pharmaceuticals

At WuXi Biologics, we celebrated the end of Engineering Week 2025 with a dynamic Lunch and Learn session! We welcomed GEMÜ Group and SCRI-IS Technologies Ltd. to explore the latest industry innovations and foster engineering education. It's vital to stay connected and share expertise to propel our industry forward. We appreciated everyone's participation and hope you had a fantastic Engineering Week! #EngineersWeek #Innovation #WuXiBiologics  

When it comes to complex molecules, we believe in keeping your analytics simple. At WuXi Biologics, Analytical Sciences and Clinical Quality Control team up to provide unparalleled testing capacity across a wide range of biologics. With our global network of state-of-the-art labs, we deliver tailored solutions to your doorstep—no rigid service models. From method development to qualification and validation, we tailor every service to meet your needs, freeing you to focus on the intricate modalities that matter most. Ready to simplify your analytics? Let’s connect and find a solution. https://lnkd.in/ensHBRYQ #ComplexMolecules #AnalyticsSimplified #BiologicsTesting #MethodDevelopment #ValidationServices #ClinicalQualityControl #AnalyticaltTesting

Power your CHO cell bank with confidence. WuXi Biologics delivers rigorous, cost-efficient characterization services to ensure identity, purity, stability, and safety—fast. Our globally trusted approach accelerates compliance, streamlining your path to filing. ✅ Proven expertise – 2,500+ characterizations completed ✅ Regulatory excellence – Trusted worldwide with global certifications ✅ Accelerated timelines – Fully in-house testing eliminates delays ✅ Cutting-edge technology – NGS and qPCR enable rapid release Learn more: https://lnkd.in/eG4nxrYF #CellBank #Biologics #RegulatoryExcellence #QualityControl

Calling all aspiring DKIT Engineers! 📣 WuXi Biologics is heading to the Engineering Futures Careers Fair at DKIT (Dundalk Institute of Technology) on Wednesday, March 26th, from 9:00 AM to 2:00 PM. Join us on the DKIT campus for a fantastic opportunity to explore exciting career paths in engineering within the dynamic and growing field of biopharmaceuticals. Are you passionate about innovation and making a real impact? Then come chat with our knowledgeable team members. We'll be showcasing the diverse engineering roles available at WuXi Biologics. Discover how you can contribute to cutting-edge projects and advance your career in a globally leading company right here in Dundalk. Don't miss this chance to take your engineering career to the next level. We're looking forward to meeting the talented engineering students of DKIT. #DKIT #CareersFair #EngineeringJobs

In biologics manufacturing, traditional scale-up increases the volume in a single bioreactor. While efficient for large-scale production, this approach introduces complexities and challenges in maintaining consistent quality at larger volumes. To ensure flexible and responsive production, we scale out: 🧪 Same-size bioreactors running in parallel adapt easily to fluctuating demand. 🧪 Multiple bioreactors minimize the impact of a batch failure. 🧪 Smaller bioreactors avoid the inefficiencies and risks of scaling a large single bioreactor. 🧪 Uniform bioreactor scaling across facilities and regions reduces variability. Learn more about scaling out at https://lnkd.in/epb3BUxU #BiologicsManufacturing #ScaleOut #Bioreactors #Biomanufacturing #QualityControl #ProcessDevelopment #Bioprocessing

Celebrating a truly inspiring International Women's Day at WuXi Biologics!💜 We were absolutely honoured to host Lorraine Higgins, Managing Director of Rockwood Public Affairs, esteemed barrister, and former Senator of Seanad Eireann, as our guest speaker. Her powerful message of resilience, leadership, and empowerment resonated deeply with every member of our team. Lorraine shared invaluable insights from her remarkable career journey, highlighting the importance of breaking barriers and supporting women in all fields. Her words sparked meaningful conversations and left us feeling motivated and inspired. A heartfelt thank you, Lorraine, for sharing your wisdom and empowering us to strive for excellence! We are proud to celebrate the achievements of women everywhere and reaffirm our commitment to fostering an inclusive and equal workplace. #IWD2024 #InternationalWomensDay #WomenInLeadership